MEDICLINIC INTERNATIONAL PLC Mediclinic International plc (Incorporated in England and Wales) Company Number: 08338604
LSE Share Code: MDC
JSE Share Code: MEI
NSX Share Code: MEP
ISIN: GB00B8HX8Z88
LEI: 2138002S5BSBIZTD5I60
("Mediclinic", the "Company", or the "Group")
29 July 2022
TR-1: Standard form for notification of major holdings
1. Issuer Details
ISIN
GB00B8HX8Z88
Issuer Name
MEDICLINIC INTERNATIONAL PLC
UK or Non-UK Issuer
UK
2. Reason for Notification
An acquisition or disposal of financial instruments
3. Details of person subject to the notification obligation Name
JPMorgan Chase & Co.
City of registered office (if applicable)
Country of registered office (if applicable)
US
4. Details of the shareholder
Name | City of registered office | Country of registered office | |||
J.P. Morgan Securities plc
- Date on which the threshold was crossed or reached 27-Jul-2022
- Date on which Issuer notified
29-Jul-2022
7. Total positions of person(s) subject to the notification obligation
% of voting | % of voting rights | Total of both | Total number | |||||
. | rights attached | through financial | in % (8.A + | of voting rights | ||||
to shares (total | instruments (total | 8.B) | held in issuer | |||||
of 8.A) | of 8.B 1 + 8.B 2) | |||||||
Resulting | 0.951405 | 6.162299 | 7.113704 | 52445759 | ||||
situation on the | ||||||||
date on which | ||||||||
threshold was | ||||||||
crossed or | ||||||||
reached | ||||||||
Position of | 0.949276 | 6.028796 | 6.978072 | |||||
previous | ||||||||
notification (if | ||||||||
applicable) | ||||||||
8. Notified details of the resulting situation on the date on which the threshold was crossed or reached
8A. Voting rights attached to shares
Class/Type of | Number of direct | Number of indirect | % of direct | % of indirect | |
shares ISIN | voting rights | voting rights | voting rights | voting rights | |
code(if possible) | (DTR5.1) | (DTR5.2.1) | (DTR5.1) | (DTR5.2.1) | |
GB00B8HX8Z88 | 7014177 | 0.951405 | |||
Sub Total 8.A | 7014177 | 0.951405% | |||
8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))
Type of financial | Expiration | Exercise/conversion | Number of voting rights that | % of | |||
instrument | date | period | may be acquired if the | voting | |||
instrument is | rights | ||||||
exercised/converted | |||||||
Sub Total 8.B1 |
8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))
Type of | Expiration date | Exercise/conversion | Physical or | Number of | % of voting | |
financial | period | cash | voting rights | rights | ||
instrument | settlement | |||||
Cash- | ||||||
settled | 23/11/2022 | 23/11/2022 | Cash | 25091493 | 3.403408 | |
Equity | ||||||
Swap | ||||||
Cash- | ||||||
settled | 04/01/2023 | 04/01/2023 | Cash | 137352 | 0.018629 | |
Equity | ||||||
Swap | ||||||
Type of | Expiration date | Exercise/conversion | Physical or | Number of | % of voting | |
financial | period | cash | voting rights | rights | ||
instrument | settlement | |||||
Cash- | 01/02/2023 | 01/02/2023 | Cash | 16152 | 0.002190 | |
settled | ||||||
Equity | ||||||
Swap | ||||||
Cash- | 22/02/2023 | 22/02/2023 | Cash | 44345 | 0.006012 | |
settled | ||||||
Equity | ||||||
Swap | ||||||
Cash- | 17/03/2023 | 17/03/2023 | Cash | 14682 | 0.001990 | |
settled | ||||||
Equity | ||||||
Swap | ||||||
Cash- | 30/05/2023 | 30/05/2023 | Cash | 99 | 0.000013 | |
settled | ||||||
Equity | ||||||
Swap | ||||||
Cash- | 02/06/2023 | 02/06/2023 | Cash | 12940451 | 1.755237 | |
settled | ||||||
Equity | ||||||
Swap | ||||||
Cash- | 04/07/2023 | 04/07/2023 | Cash | 6606429 | 0.896087 | |
settled | ||||||
Equity | ||||||
Swap | ||||||
Cash- | 12/07/2023 | 12/07/2023 | Cash | 24807 | 0.003360 | |
settled | ||||||
Equity | ||||||
Swap | ||||||
Cash- | 09/08/2023 | 09/08/2023 | Cash | 759 | 0.000102 | |
settled | ||||||
Equity | ||||||
Swap | ||||||
Cash- | 16/08/2023 | 16/08/2023 | Cash | 15000 | 0.002033 | |
settled | ||||||
Equity | ||||||
Swap | ||||||
Cash- | 21/08/2023 | 21/08/2023 | Cash | 585 | 0.000078 | |
settled |
Type of | Expiration date | Exercise/conversion | Physical or | Number of | % of voting | |
financial | period | cash | voting rights | rights | ||
instrument | settlement | |||||
Equity | ||||||
Swap | ||||||
Cash- | 22/08/2023 | 22/08/2023 | Cash | 598 | 0.000081 | |
settled | ||||||
Equity | ||||||
Swap | ||||||
Cash- | 19/01/2024 | 19/01/2024 | Cash | 44403 | 0.006021 | |
settled | ||||||
Equity | ||||||
Swap | ||||||
Cash- | 05/01/2027 | 05/01/2027 | Cash | 429053 | 0.058193 | |
settled | ||||||
Equity | ||||||
Swap | ||||||
Cash- | 06/07/2027 | 06/07/2027 | Cash | 93 | 0.000012 | |
settled | ||||||
Equity | ||||||
Swap | ||||||
Cash- | 09/07/2029 | 09/07/2029 | Cash | 65281 | 0.008853 | |
settled | ||||||
Equity | ||||||
Swap | ||||||
Sub Total 8.B2 | 45431582 | 6.162299% | ||||
9. Information in relation to the person subject to the notification obligation
2. Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entities (please add additional rows as necessary)
Ultimate | Name of controlled | % of voting | % of voting rights | Total of both if it | ||
controlling person | undertaking | rights if it | through financial | equals or is higher | ||
equals or is | instruments if it | than the notifiable | ||||
higher than | equals or is higher | threshold | ||||
the notifiable | than the notifiable | |||||
threshold | threshold | |||||
JPMorgan | J.P. Morgan | 6.162299 | 6.162299% | |||
Chase & Co. | Securities plc | |||||
JPMorgan | JPMorgan | |||||
Chase & Co. | Chase Bank, | |||||
National | ||||||
Association | ||||||
Ultimate | Name of controlled | % of voting | % of voting rights | Total of both if it | ||
controlling person | undertaking | rights if it | through financial | equals or is higher | ||
equals or is | instruments if it | than the notifiable | ||||
higher than | equals or is higher | threshold | ||||
the notifiable | than the notifiable | |||||
threshold | threshold | |||||
JPMorgan | J.P. Morgan | |||||
Chase & Co. | Equities | |||||
South Africa | ||||||
Proprietary | ||||||
Limited | ||||||
JPMorgan | J.P. Morgan | |||||
Chase & Co. | SE | |||||
10. In case of proxy voting Name of the proxy holder
The number and % of voting rights held
The date until which the voting rights will be held
11. Additional Information Chain of controlled undertakings:
JPMorgan Chase & Co.
JPMorgan Chase Bank, National Association (100%)
J.P. Morgan International Finance Limited (100%)
J.P. Morgan Capital Holdings Limited (100%)
J.P. Morgan Securities plc (100%)
JPMorgan Chase & Co.
JPMorgan Chase Bank, National Association (100%)
JPMorgan Chase & Co.
JPMorgan Chase Bank, National Association (100%) J.P. Morgan International Finance Limited (100%) J.P. Morgan Capital Holdings Limited (100%)
J.P. Morgan Equities South Africa Proprietary Limited (100%)
JPMorgan Chase & Co.
JPMorgan Chase Bank, National Association (100%)
J.P. Morgan International Finance Limited (100%)
J.P. Morgan SE (100%)
-
Date of Completion
29-Jul-2022 - Place Of Completion
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Mediclinic International plc published this content on 29 July 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 29 July 2022 13:29:13 UTC.
